Long-Acting Drug Delivery Systems: Pharmaceutical, Clinical, and Regulatory Aspects

AIDS Cancer Schizophrenia Microelectronics Nanoparticles. Biocompatibility Infections Controlled release Contraception Imaging Atherosclerosis Chronic diseases Biodegradation Stents Coronary Artery Disease Optical Imaging EPR ESR Regulatory affairs Biodegradable polymers Personalized therapy Response Spectroscopy Antipsychotics Endocrine Inflammatory Biomaterials Nanocarriers Polymer Implants Drug-Delivery Treatment adherence Site-specific delivery Degradation 3D printing Transdermal delivery MRI Cardiovascular Disease Sustained-release Implantable devices Neurodegenerative Sexual and reproductive health Bioresorbable Anterior segment long-acting systems Epicardial patch Control release Implantable delivery In situ forming implants for ocular delivery Intravitreal delivery Long acting Long-acting implantable drug delivery system Long-acting drug delivery Long-acting injectable Nano/microparticles Microneedles Gynecological cancers Nano/microparticulate systems for ocular delivery Periocular delivery Posterior segment long-acting systems Intradermal delivery In situ forming implant ISO-10993-13 Long-acting injections Microneedle Arrays Local penetration Long-acting drug delivery systems Long-acting implants Long-acting therapy